AnalystsJustin KimJustin Kim's Stock Forecasts
AnalystsJustin Kim
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4538 out of 4870 analysts
Average Return
-6.13%
Win Rate
41%14 out of 34
Risk vs Reward
Poor
Good
Justin Kim's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Provention Bio IncPRVB | +209.16% | $8.08 | $24.98 | 2022-11-17 - 2023-04-27 | Buy |
Chinook Therapeutics IncKDNY | +85.11% | $21.82 | $40.39 | 2023-02-27 - 2023-08-10 | Buy |
Pharvaris NvPHVS | +81.98% | $10.99 | $20.00 | 2022-08-22 - 2023-08-22 | Buy |
Chinook Therapeutics IncKDNY | +76.99% | $22.82 | $40.39 | 2023-02-20 - 2023-08-10 | Buy |
Cytokinetics IncCYTK | +67.57% | $43.11 | $72.24 | 2023-02-28 - 2024-02-29 | Buy |
Justin Kim Analyst Color
Get additional color on Justin Kim's coverage of popular stocks
Justin Kim's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apellis Pharmaceuticals IncAPLS | 5 | Buy | $40.00 | +99.20% | Maintains | 6 months ago |
Pharvaris NvPHVS | 4 | Buy | $42.00 | +135.29% | Maintains | 8 months ago |
Cytokinetics IncCYTK | 5 | Buy | $106.00 | +146.97% | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 5 | Buy | $87.00 | N/A | Reiterates | a year ago |
Vera Therapeutics IncVERA | 1 | Buy | $26.00 | N/A | Initiates Coverage On | a year ago |
Zura Bio LtdZURA | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $14.00 | N/A | Reiterates | 2 years ago |
Chinook Therapeutics IncKDNY | 2 | Buy | $34.00 | N/A | Maintains | 2 years ago |
Provention Bio IncPRVB | 3 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Aurinia Pharmaceuticals IncAUPH | 5 | Hold | N/A | N/A | Downgrades | 2 years ago |
Biocryst Pharmaceuticals IncBCRX | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ionis Pharmaceuticals IncIONS | 1 | Buy | $59.00 | N/A | Assumes | 3 years ago |
Elicio Therapeutics IncELTX | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.